Page last updated: 2024-08-23

etoposide and lde225

etoposide has been researched along with lde225 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Berger, MF; Fleisher, M; Holodny, AI; Kris, MG; Krug, LM; Litvak, AM; Ng, KK; Pietanza, MC; Rudin, CM; Sima, CS; Teitcher, JB; Varghese, AM; Won, HH; Woo, KM	1

Trials

1 trial(s) available for etoposide and lde225

Article	Year
A phase I trial of the Hedgehog inhibitor, sonidegib (LDE225), in combination with etoposide and cisplatin for the initial treatment of extensive stage small cell lung cancer. Lung cancer (Amsterdam, Netherlands), 2016, Volume: 99 Topics: Antineoplastic Combined Chemotherapy Protocols; Biphenyl Compounds; Cisplatin; Etoposide; Female; Hedgehog Proteins; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Neoplasm Staging; Neoplastic Cells, Circulating; Pyridines; Small Cell Lung Carcinoma; Treatment Outcome	2016

Article

Year

A phase I trial of the Hedgehog inhibitor, sonidegib (LDE225), in combination with etoposide and cisplatin for the initial treatment of extensive stage small cell lung cancer.

Lung cancer (Amsterdam, Netherlands), 2016, Volume: 99

Topics: Antineoplastic Combined Chemotherapy Protocols; Biphenyl Compounds; Cisplatin; Etoposide; Female; Hedgehog Proteins; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Neoplasm Staging; Neoplastic Cells, Circulating; Pyridines; Small Cell Lung Carcinoma; Treatment Outcome

2016